Current status and advances of immunotherapy in nasopharyngeal carcinomaJianying Xu, Feng‐Hua Wang, Yiqin Wang et al.|Therapeutic Advances in Medical Oncology|2022Cited by 75
Association of Plasma Epstein-Barr Virus DNA With Outcomes for Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Receiving Anti–Programmed Cell Death 1 ImmunotherapyJianying Xu, Feng‐Hua Wang, Fei Han et al.|JAMA Network Open|2022Cited by 64
Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancerXiaoli Wei, Rui‐Hua Xu, De‐Shen Wang et al.|Therapeutic Advances in Medical Oncology|2021Cited by 39